The Conduct of Clinical Trials of Treatments during Public Health Emergencies: A Health Policy and Bioethics Consortium
Couldn't join us for the event? Check out the panelists' slide presentations below!
Description
In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best conduct clinical trials and development of vaccines in the context of an epidemic or outbreak.
At this panel discussion, two health policy experts examined the appropriate conduct of clinical trials during public health emergencies.
Panelists
-
Susan Ellenberg, Professor Of Biostatistics, Biostatistics And Epidemiology, the Hospital of the University Of Pennsylvania and Director, Biostatistics And Data Management Core, Penn Center For AIDS Research
-
Jason Schwartz, Assistant Professor of Public Health (Health Policy), Yale School of Public Health and Assistant Professor, Program in the History of Science and Medicine, Yale University
-
Moderator: Carmel Shachar, Executive Director, the Petrie-Flom Center, and Lecturer on Law, Harvard Law School
This event was free and open to the public.
Learn more!
Learn more about the Health Policy and Bioethics Consortia.
Slide Presentations
-
Susan Ellenberg, "Evaluating Treatments in Settings Demanding Urgency: Lessons from the 2014-2015 Ebola Epidemic"
-
Jason Schwartz, "Clinical Trials and Public Health Emergencies"
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.
Videos
VIDEO: Aaron S. Kesselheim, Welcoming Remarks
VIDEO: Carmel Shachar, Welcoming Remarks
VIDEO: Jason Schwartz, Clinical Trials and Public Health Emergencies
Tags
bioethics clinical research global health health law policy health policy and bioethics consortia infectious diseases medical safety public health vaccines